Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jacob Frenkel

Brainstorm Cell Therapeutics Inc. reported in an 8-K filed July 30, 2026 that Jacob Frenkel was appointed Senior Advisor.

“Professor Jacob Frenkel, who has anchored BrainStorm's leadership since joining its advisory board in 2007 alongside the late Harvey Krueger and served as Board Chairman since 2020, will transition into the role of Senior Advisor.”
Brainstorm Cell Therapeutics Inc. Form 8-K, filed July 30, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Brainstorm Cell Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.